Cited by 31interferon and immune responsesCytokine Signaling Pathways and InteractionsProtein Tyrosine Phosphatases

Cells Previously Desensitized to Type 1 Interferons Display Different Mechanisms of Activation of Stat-dependent Gene Expression from Naïve Cells

Open access
Sakamoto, Shuji, Qin, Jinzhong, Navarro, Angels, Gamero, Ana, Potla, Ramesh, Yi, Taolin, Zhu, Wei, Baker, Darren P. +2 more·2004·Journal of Biological Chemistry

Abstract

Over the past decade, a wealth of knowledge has been obtained concerning the mechanisms by which interferons (IFNs) and other cytokines activate or down-regulate immediate early genes via the Jak/Stat pathway. In contrast, little information is available on interferon-activated gene expression in naïve cells compared with cells that have been desensitized and subsequently resensitized to the actions of these cytokines. In naïve cells, the ISG54 gene is activated via IFN beta-stimulated formation of ISGF3, a heterotrimeric DNA binding complex consisting of p48 (IRF9) and tyrosine-phosphorylated Stat1 and Stat2. In contrast, in previously desensitized cells IFN beta weakly stimulates the assembly of an ISGF3-like complex that lacks Stat1, even though ISG54 mRNA induction is the same as in naïve cells. The lack of Stat1 tyrosine phosphorylation and DNA binding is due to increased activity of a protein-tyrosine phosphatase. In cells that do not express the tyrosine phosphatase Tc-PTP, the rate of Stat1 dephosphorylation is the same in naïve and previously desensitized cells. These results implicate Tc-PTP in a novel role in the regulation of type 1 interferon-stimulated gene expression.

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1074/jbc.m309631200

Cites

3 of 3 references verified0 citation errors · 0 not checkable

Statistics

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

  • T-cell protein-tyrosine phosphatase has been shown to potently desensitize cells to repeated IFNγ stimulation.

    “In the case of IFN␥ signaling, the T-cell protein-tyrosine phosphatase has been shown to potently desensitize cells to repeated stimulation (28).”

    From The Comparative Roles of Suppressor of Cytokine Signaling-1 and -3 in the Inhibition and Desensitization of Cytokine Signaling (2006) · cites this paper as [28]

    The Results passages describing Figs. 5–6 show reduced IFNγ-induced Stat1 activation after IFNβ pretreatment and implicate Tc-PTP in enhanced Stat1 dephosphorylation. They do not show desensitization caused by repeated IFNγ stimulation; the prior exposure was to IFNβ. Page numbers are not available in our copy. (LLM, conf=0.88)

    Experimental — accuracy not yet measured
  • Factors other than SOCS1, such as T-cell protein-tyrosine phosphatase, also have an important role in desensitizing cells to IFNγ.

    “This result also highlighted the important role that factors other than SOCS1, such as T-cell protein-tyrosine phosphatase for instance (28), also have in desensitizing cells to IFN␥.”

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Cites

Flagged first, then by citations

Research works printed but not linked: 9

  1. Liu, B., Liao, J., Rao, X., Kushner, S. A., Chung, C. D., Chang, D. D., and Shuai, K. (1998) Proc. Natl. Acad. Sci. U. S. A. 95, 10626 -10631
  2. Schmidt, D., and Muller, S. (2002) Proc. Natl. Acad. Sci. U. S. A. 99, 2872-2877
  3. Wilson, K. C., and Finbloom, D. S. (1992) Proc. Natl. Acad. Sci. U. S. A. 89, 11964 -11968
  4. Paulson, M., Press, C., Smith, E., Tanese, N., and Levy, D. E. (2002) Nat. Cell Biol. 4, 140 -147
  5. Reich, N., Evans, B., Levy, D. E., Fahey, D., Knight, E., and Darnell, J. E., Jr. (1987) Proc. Natl. Acad. Sci. U. S. A. 84, 6394 -6398
  6. Larner, A. C., Jonak, G., Cheng, Y.-S. E., Korant, B., Knight, E., and Darnell, J. E. (1984) Proc. Natl. Acad. Sci. U. S. A. 81, 6733-6737
  7. Pearse, R. N., Feinman, R., and Ravetch, J. V. (1991) Proc. Natl. Acad. Sci.
  8. Dale, T. C., Ali Imam, A. M., Kerr, I. M., and Stark, G. R. (1989) Proc. Natl. Acad. Sci. U. S. A. 86, 1203-1207
  9. Qureshi, S. A., Salditt-Georgieff, M., and Darnell, J. E., Jr. (1995) Proc. Natl. Acad. Sci. U. S. A. 92, 3829 -3833

Cited by

Sorted by citations

Authors
Sakamoto, S., Qin, J., Navarro, A., Gamero, A., Potla, R., Yi, T., Zhu, W., Baker, D. P., Feldman, G., & Larner, A. C.
Affiliations
  • Cleveland Clinic (US)
  • Cleveland Clinic Research (US)
  • Biogen (United States) (US)
  • Center for Biologics Evaluation and Research (US)
Corresponding author
Larner, Andrew C.
Venue
Journal of Biological Chemistry
Publisher
Elsevier BV
Published
2004-01
Volume
279
Issue
5
Pages
3245-3253
ISSN
0021-9258 (ISSN-L)
OpenAlex
W2033067962
Cited by
31
References
3
Citations by year
2026: 2 · 2025: 2 · 2022: 1 · 2019: 1 · 2018: 1 · 2015: 1 · 2014: 2 · 2013: 1 · 2012: 2
FWCI
1.20
Type
journal article
Language
en
Open access
Locations
  • Journal of Biological Chemistry (publishedVersion, cc-by)
  • PubMed (publishedVersion)
Funders
  • National Institutes of Health (5r01ca077366-05)
  • National Cancer Institute (CA77366)
Topics
  • Life Sciences › Immunology and Microbiology › Immunology › interferon and immune responses
  • Health Sciences › Medicine › Oncology › Cytokine Signaling Pathways and Interactions
  • Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Protein Tyrosine Phosphatases
Keywords
type I interferon, interferon-beta, STAT1, STAT2, IRF9, ISGF3, ISG54, JAK/STAT signaling, protein tyrosine phosphatase, TCPTP, interferon-stimulated gene expression
MeSH terms
Animals, Cell Line, Cell Nucleus, Cells, Cultured, Chromatin, Cytoplasm, DNA-Binding Proteins, Gene Expression Regulation, Humans, Immunoglobulins, Interferon Type I, Membrane Proteins, Phosphorylation, Precipitin Tests, Protein Binding, RNA, RNA, Messenger, Time Factors, Tyrosine, Blotting, Western, Trans-Activators, Down-Regulation, Interferon-beta, Protein Tyrosine Phosphatases, STAT1 Transcription Factor, Mice, Protein Tyrosine Phosphatase, Non-Receptor Type 1, Protein Tyrosine Phosphatase, Non-Receptor Type 2

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review